The Inhibition by Plasma of Urokinase and Tissue Activator-Induced Fibrinolysis in Pregnancy and the Puerperium

Summary

The activity of urokinase and tissue activator on fibrin plates was inhibited by plasma from women in the third trimester of pregnancy to a greater extent than by non-pregnant plasma. Pregnancy also inhibited the amidolytic activity of urokinase. The high molecular weight fractions of pregnancy plasma gel filtered on Sephadex G-200 showed comparable inhibitory activity against urokinase as fractions for non-pregnant plasma; in contrast with non-pregnant plasma, the lower molecular weight fractions of pregnancy plasma were markedly inhibitory against urokinase. Plasma exposed to lysine-Sepharose to remove plasminogen and then fractionated on Sephadex G-100 provided a pattern of three areas of inhibition against tissue activator similar to that seen in non-pregnant plasma. The urokinase-inhibitory activity of lower molecular weight fractions of plasma separated on Sephadex G-200 fell within 1 hr of delivery and fell further over the following 18 to 30 hr.

Keywords

Tissue activators - Plasma inhibitors of fibrinolysis - Pregnancy

• References

• 1 Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J 1970; 02: 200-203
• 2 Condie RG, Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol 1976; 83: 938-942
• 3 Brakman P, Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand J clin Lab Invest 1963; 15: 603-609
• 4 Kawano T, Morunoto K, Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253-254
• 5 Nilsson IM, Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand 1967; 46: 273-285
• 6 Bonnar J, McNicol GP, Douglas AS. Fibrinolytic enzyme system and pregnancy. Br Med J 1969; 03: 387-389
• 7 Hedner U, Astedt B. Study of fibrinolytic inhibitors during pregnancy. Acta Obstet Gynecol Scand 1971; 50: 99-103
• 8 Rickli EE, Zaugg H. Isolation and purification of highly enriched tissue plasminogen activator from pig heart. Thrombos Diathes HaemorTh 1970; 23: 64-76
• 9 Beattie AG, Ogston D, Bennett NB, Douglas AS. Inhibitors of plasminogen activation in human blood. Br J Haematol 1976; 32: 135-143
• 10 Thorsen S. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects. Scand I Clin Lab Invest 1973; 31: 51-59
• 11 Walker JE, Ogston D. The inhibition of tissue activator and urokinase by human plasma. Thromb Haemostas 1982; 47: 265-268
• 12 Walker JE, Campbell DM, Ogston D. Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol 1982; 89: 208-210
• 13 Thorsen S, Glas-Greenwalt P, Astrup T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombos Diathes Haemorrh 1972; 28: 65-74
• 14 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-2919
• 15 Wun T-C, Schleuning W-D, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982; 257: 3276-3283
• 16 Holmberg L, Leeander I, Persson B, Astedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta 1978; 544: 128-137